Novo Nordisk A/S And Innate Pharma To Develop Drugs To Support "Natural Killer" Cells

COPENHAGEN (AFX) - Novo Nordisk AS said it has formed a partnership with French biopharmaceutical company Innate Pharma SA, to develop new drugs to support what are called 'natural killer' (NK) cells, one of the body's first lines of defence against cancer cells and infections.

Back to news